News

Acquires a highly selective and brain penetrant NLRP3 inhibitor from Mwyngil Therapeutics Company's lead candidate BT-267, a ...
Bristol Myers Squibb is undervalued despite challenges. Learn how BMY stock's strong pipeline, cash flow, and growth ...
Coforge is adopting strategies similar to Cognizant and Infosys' by placing business consultants at client sites to increase ...
Scott Brook Preserve has adapted trails to navigate around four dams built by these natural engineers. It's also a great spot ...
Prestige Estates overall volumes rose to ~9.6msf, up 234% Y-o-Y and 113% Q-o-Q, signaling robust demand across its offerings, ...
The death of a Russian Cabinet minister in a field near his posh home in a Moscow suburb has fueled wild speculation about ...
THE thrills and spills of the summer transfer window are well underway with some huge deals in the pipeline over the next few ...
India’s leading IT firm, reported a 6% year-on-year rise in consolidated net profit at ₹12,760 crore for Q1FY26, compared to ...
The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...